295 related articles for article (PubMed ID: 3022031)
21. Identification and characterisation in vitro of cells with a non-SCLC cell-like phenotype derived from a continuous SCLC cell line.
Khan MZ; Freshney RI; Murray AM; Merry S; Plumb JA; McNicol AM
Anticancer Res; 1991; 11(5):1687-95. PubMed ID: 1662924
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical study of small cell lung carcinoma; with special reference to the neuroendocrine markers aromatic L-amino acid decarboxylase and gastrin-releasing peptide.
Nakajima T; Shimosato Y; Morinaga S; Terasaki T; Tsumuraya M; Yamaguchi K; Ichinose H; Nagatsu T; Kato K; Nakazato Y
Jpn J Clin Oncol; 1986 Sep; 16(3):223-33. PubMed ID: 2430122
[TBL] [Abstract][Full Text] [Related]
23. [Serum neuron-specific enolase as a marker of lung cancers].
Fujisawa T; Yamaguchi Y; Sasaki K; Fukazawa T; Hongo H; Ogawa T; Kimura H
Gan To Kagaku Ryoho; 1985 Jan; 12(1):139-43. PubMed ID: 2981514
[TBL] [Abstract][Full Text] [Related]
24. [Serial measurements of serum carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) during chemotherapy of patients with inoperable lung cancer].
Fukuoka M; Takada M; Kamei T; Negoro S; Kusunoki Y; Matsui K; Ryu S; Sakai N; Takifuji N; Masuda N
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):871-80. PubMed ID: 3032108
[TBL] [Abstract][Full Text] [Related]
25. Markers and characteristics of human SCLC cell lines. Neuroendocrine markers, classical tumor markers, and chromosomal characteristics of permanent human small cell lung cancer cell lines.
Bepler G; Jaques G; Koehler A; Gropp C; Havemann K
J Cancer Res Clin Oncol; 1987; 113(3):253-9. PubMed ID: 2438285
[TBL] [Abstract][Full Text] [Related]
26. Predictive and prognostic significance of neuron-specific enolase (NSE) in non-small cell lung cancer.
Tiseo M; Ardizzoni A; Cafferata MA; Loprevite M; Chiaramondia M; Filiberti R; Marroni P; Grossi F; Paganuzzi M
Anticancer Res; 2008; 28(1B):507-13. PubMed ID: 18383893
[TBL] [Abstract][Full Text] [Related]
27. ProGRP and NSE in therapy monitoring in patients with small cell lung cancer.
Wójcik E; Kulpa JK; Sas-Korczyńska B; Korzeniowski S; Jakubowicz J
Anticancer Res; 2008; 28(5B):3027-33. PubMed ID: 19031951
[TBL] [Abstract][Full Text] [Related]
28. [Clinical significance of the measurement of serum neuron-specific enolase levels in patients with lung cancer].
Yumoto Y; Shiota T; Tamai M; Okabe K; Kiura K; Shimoe T; Fujii M
Gan To Kagaku Ryoho; 1986 Jun; 13(6):2089-93. PubMed ID: 3013098
[TBL] [Abstract][Full Text] [Related]
29. Cut-off levels of NSE to differentiate SCLC from NSCLC.
Satoh H; Ishikawa H; Kurishima K; Yamashita YT; Ohtsuka M; Sekizawa K
Oncol Rep; 2002; 9(3):581-3. PubMed ID: 11956631
[TBL] [Abstract][Full Text] [Related]
30. Pro-gastrin-releasing peptide (ProGRP), neuron specific enolase (NSE), carcinoembryonic antigen (CEA) and cytokeratin 19-fragments (CYFRA 21-1) in patients with lung cancer in comparison to other lung diseases.
Schneider J; Philipp M; Velcovsky HG; Morr H; Katz N
Anticancer Res; 2003; 23(2A):885-93. PubMed ID: 12820318
[TBL] [Abstract][Full Text] [Related]
31. [Pathology and biology of small cell lung cancer].
Shimosato Y
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):952-8. PubMed ID: 2839114
[TBL] [Abstract][Full Text] [Related]
32. [Serum neuron specific enolase (NSE) levels in patients with non small cell lung cancer].
Shibayama T; Ohnoshi T; Ueoka H; Horiguchi T; Kodani T; Segawa Y; Maeda T; Miyatake K; Takigawa N; Kimura I
Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Jun; 30(6):1097-102. PubMed ID: 1324376
[TBL] [Abstract][Full Text] [Related]
33. Establishment and identification of small cell lung cancer cell lines having classic and variant features.
Carney DN; Gazdar AF; Bepler G; Guccion JG; Marangos PJ; Moody TW; Zweig MH; Minna JD
Cancer Res; 1985 Jun; 45(6):2913-23. PubMed ID: 2985257
[TBL] [Abstract][Full Text] [Related]
34. Serum pseudouridine as a biochemical marker in small cell lung cancer.
Tamura S; Fujioka H; Nakano T; Hada T; Higashino K
Cancer Res; 1987 Nov; 47(22):6138-41. PubMed ID: 2822241
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of pretreatment carcinoembryonic antigen, neuron-specific enolase, and creatine kinase-BB levels in sera of patients with small cell lung cancer.
Jaques G; Bepler G; Holle R; Wolf M; Hannich T; Gropp C; Havemann K
Cancer; 1988 Jul; 62(1):125-34. PubMed ID: 2838147
[TBL] [Abstract][Full Text] [Related]
36. Levels of creatine kinase and its BB isoenzyme in lung cancer specimens and cultures.
Gazdar AF; Zweig MH; Carney DN; Van Steirteghen AC; Baylin SB; Minna JD
Cancer Res; 1981 Jul; 41(7):2773-7. PubMed ID: 6265067
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of carcinoembryonic antigen (CEA) and brain-type creatine kinase (CK-BB) in serum from patients with carcinoma of the lung.
Nikliński J; Furman M; Laudański J; Pałynyczko Z; Welk M
Neoplasma; 1991; 38(2):129-35. PubMed ID: 1645850
[TBL] [Abstract][Full Text] [Related]
38. [Clinical significance of ProGRP31-98 in patients with small-cell lung cancer].
Yang J; Li R; Li A
Zhonghua Zhong Liu Za Zhi; 2000 May; 22(3):216-8. PubMed ID: 11778234
[TBL] [Abstract][Full Text] [Related]
39. Doubling time of neuron-specific enolase and survival in small cell lung cancer patients. Results of a preliminary analysis.
Splinter TA; Cooper EH; Oosterom R; Peake MD; Brown DA; Kho GS
Eur J Respir Dis Suppl; 1987; 149():37-44. PubMed ID: 3034646
[TBL] [Abstract][Full Text] [Related]
40. Neuron specific enolase tissue expression as a prognostic factor in advanced non small cell lung cancer.
Petrovic M; Tomic I; Plavec G; Ilic S; Ilic N; Baskic D
J BUON; 2008; 13(1):93-6. PubMed ID: 18404793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
